ENGS ENGS
Company Profile ↓Company Overview
ENGS (ENGS) is a publicly traded company listed on with a market capitalization of $37.91M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 55.5%, reflecting efficient use of shareholder capital.
Revenue has grown at a 39.1% CAGR over the past five years.
Recent Developments
- Jun 2024 Revenue of $9.60M (+59.9% YoY); net profit $-1.11M.
- Trailing 12 Months Year-on-year growth — revenue +59.9%.
- 5-Year Trend Long-term compounding — revenue CAGR 39.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 39.14% |
| 1 Year: | 59.88% |
Stock Price Performance
| 1 Year: | -11.63% |
| 6 Months: | +168.96% |
| 3 Months: | +104.62% |
| 1 Month: | -6.01% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- Golden Cross8d ago
- RSI (14)53.56 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 55.5%.
- Compounding revenue at 39.1% over 5 years.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 78.2% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 |
|---|---|---|---|
| Revenue | 4.96M | 6.01M | 9.60M |
| Cost of Revenue | 3.88M | 4.92M | 7.46M |
| Gross Profit | 1.08M | 1.08M | 2.14M |
| Operating Expenses | 2.17M | 2.59M | 2.38M |
| Operating Income | -1.09M | -1.50M | -233.09K |
| EBITDA | -1.04M | -1.58M | -417.18K |
| Interest Expense | 313.75K | 382.01K | 553.28K |
| Pretax Income | -1.62M | -2.11M | -1.11M |
| Tax Provision | -88.94K | 176.92K | 2.51K |
| Net Income | -1.53M | -2.28M | -1.11M |
| Diluted EPS | -0.11 | -0.16 | -0.08 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 |
|---|---|---|---|
| Total Assets | 8.64M | 7.94M | 8.68M |
| Current Assets | 4.87M | 4.39M | 5.36M |
| Cash & Equivalents | 15.97K | 220.89K | 260.72K |
| Inventory | 2.73M | 1.82M | 1.09M |
| Receivables | 80.37K | 63.21K | 213.70K |
| Total Liabilities | 12.52M | 13.85M | 10.68M |
| Current Liabilities | 12.06M | 13.40M | 10.43M |
| Long Term Debt | 437.50K | 287.50K | 137.50K |
| Total Debt | 9.68M | 10.22M | 8.73M |
| Total Equity | -3.88M | -5.91M | -2.00M |
| Shares Outstanding | 14.25M | 14.25M | 14.25M |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 |
|---|---|---|---|
| Operating Cash Flow | -682.83K | -629.59K | -1.43M |
| Investing Cash Flow | -734.33K | -1.22K | 134.47K |
| Financing Cash Flow | 464.29K | 835.73K | 1.34M |
| Capital Expenditure | -590.29K | -1.22K | -31.89K |
| Free Cash Flow | -1.27M | -630.81K | -1.47M |
| Net Change in Cash | -952.87K | 204.92K | 39.83K |
Ratios (Annual)
Figures in %.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 |
|---|---|---|---|
| Gross Margin % | 21.8% | 18.1% | 22.3% |
| Operating Margin % | -21.9% | -25.0% | -2.4% |
| Net Margin % | -30.8% | -38.0% | -11.6% |
| ROE % | 39.3% | 38.7% | 55.5% |
| ROCE % | 31.8% | 27.5% | 13.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ENGS
Energys Group Announces Receipt of Determination Letter from Nasdaq Capital Market
BILLINGSHURST, UNITED KINGDOM, March 17, 2026 (GLOBE NEWSWIRE) -- Energys Group Limited (NASDAQ: ENGS) (“Energys Group” or the “Company”), a vertically integrated energy efficiency and decarbonization solutions provider for the build enviro…
Energys Group (ENGS): Losses Accelerate 14.1% Annually, Premium Valuation Challenged by Bearish Narrative
Energys Group (ENGS) reported accelerating net losses, with losses growing at an annual rate of 14.1% over the past five years as profit growth failed to materialize. The company’s net profit margin showed no improvement, while its price-to…
American Trust Investment Services Strengthens Executive Leadership Amid Accelerated Investment Banking Growth and Global Expansion
American Trust Investment Services, Inc. ("ATIS"), a FINRA and SEC-registered boutique investment bank and broker-dealer, today announced key updates to its executive leadership team as the firm continues its strategic transformation and ra…
ENGS — Frequently Asked Questions
What is the current share price of ENGS?
As of 2026-08-05 17:25 PDT, ENGS trades at $2.66 on NASDAQ/NYSE. Its 52-week range is $0.64 to $12.22.
What is the market capitalisation of ENGS?
ENGS has a market capitalisation of $37.91M on NASDAQ/NYSE.
What is the P/E ratio of ENGS?
ENGS trades at a trailing price-to-earnings (P/E) ratio of -34.18. Its price-to-book (P/B) ratio is -18.96.
What is the return on equity (ROE) of ENGS?
ENGS has a return on equity (ROE) of 55.45%. Its return on capital employed (ROCE) is 13.31%.
Is ENGS a good stock to buy?
This page provides a data-driven analysis of ENGS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.